Table: Fuso Pharmaceutical - Q1 parent results

Fuso Pharmaceutical Industries

09/08/2022 05:40

Aug 9 (Reuters)- 
             Fuso Pharmaceutical Industries Ltd 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2022        Jun 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             12.37               12.60            50.00    
                 (-1.8 pct)          (+1.4 pct)       (+0.7 pct)  
  Operating        622 mln             612 mln            1.60    
                 (+1.6 pct)          (-36.7 pct)      (-16.8 pct) 
  Recurring        774 mln             780 mln            1.60    
                 (-0.8 pct)          (-22.7 pct)      (-19.9 pct) 
  Net              559 mln             547 mln            1.10    
                 (+2.1 pct)          (-24.1 pct)      (-25.8 pct) 
  EPS             63.76 yen           62.45 yen       125.39 yen  
  Ann Div                             60.00 yen        60.00 yen  
  -Q2 div                             30.00 yen        30.00 yen  
  -Q4 div                             30.00 yen        30.00 yen  
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T